nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy
|
Haas, Gabriel P. |
|
2015 |
33 |
6 |
p. 269- 1 p. |
artikel |
2 |
Bench-to-bedside development of agonists and antagonists of luteinizing hormone–releasing hormone for treatment of advanced prostate cancer
|
Rick, Ferenc G. |
|
2015 |
33 |
6 |
p. 270-274 5 p. |
artikel |
3 |
Biomarker development in the context of urologic cancers
|
Kelloff, Gary J. |
|
2015 |
33 |
6 |
p. 295-301 7 p. |
artikel |
4 |
Clinical outcomes in a contemporary series of “young” patients with castration-resistant prostate cancer who were 60 years and younger
|
Caffo, Orazio |
|
2015 |
33 |
6 |
p. 265.e15-265.e21 2.64999735E23 p. |
artikel |
5 |
Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer
|
Rabow, Michael W. |
|
2015 |
33 |
6 |
p. 267.e23-267.e29 2.6699973300000003E31 p. |
artikel |
6 |
Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy
|
Lotan, Yair |
|
2015 |
33 |
6 |
p. 266.e9-266.e16 2.659999734E18 p. |
artikel |
7 |
Editorial Board
|
|
|
2015 |
33 |
6 |
p. i- 1 p. |
artikel |
8 |
Enzalutamide: Development from bench to bedside
|
Bambury, R.M. |
|
2015 |
33 |
6 |
p. 280-288 9 p. |
artikel |
9 |
Health-related quality of life after radical prostatectomy depends on patient׳s age but not on comorbidities
|
Herkommer, Kathleen |
|
2015 |
33 |
6 |
p. 266.e1-266.e7 2.659997341E9 p. |
artikel |
10 |
Masthead
|
|
|
2015 |
33 |
6 |
p. IFC- 1 p. |
artikel |
11 |
Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma
|
Singla, Nirmish |
|
2015 |
33 |
6 |
p. 268.e1-268.e7 2.679997321E9 p. |
artikel |
12 |
Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment
|
Yadav, Shalini S. |
|
2015 |
33 |
6 |
p. 267.e1-267.e13 2.669999999997331E15 p. |
artikel |
13 |
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review
|
Surcel, Cristian I. |
|
2015 |
33 |
6 |
p. 265.e1-265.e7 2.649997351E9 p. |
artikel |
14 |
Promises and challenges of fluorescence cystoscopy
|
Lotan, Yair |
|
2015 |
33 |
6 |
p. 261-264 4 p. |
artikel |
15 |
Prostate cancer detection: The impact of obesity on Asian men
|
Lee, Alvin |
|
2015 |
33 |
6 |
p. 266.e17-266.e22 2.6599734E24 p. |
artikel |
16 |
Prostate carcinoma in liver transplant recipients: Think about it!
|
Tillou, Xavier |
|
2015 |
33 |
6 |
p. 265.e9-265.e13 2.649735000000001E15 p. |
artikel |
17 |
Sources of variation in follow-up expenditure after radical cystectomy
|
Vemana, Goutham |
|
2015 |
33 |
6 |
p. 267.e31-267.e37 2.66999733E39 p. |
artikel |
18 |
Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
|
Lee, Chung-Han |
|
2015 |
33 |
6 |
p. 275-279 5 p. |
artikel |
19 |
Sunitinib dosing schedule 2/1 improves tolerability, efficacy, and health-related quality of life in Chinese patients with metastatic renal cell carcinoma
|
Pan, Xiuwu |
|
2015 |
33 |
6 |
p. 268.e9-268.e15 2.67999732E17 p. |
artikel |
20 |
Table of Contents
|
|
|
2015 |
33 |
6 |
p. ii-iii nvt p. |
artikel |
21 |
The development of abiraterone acetate for castration-resistant prostate cancer
|
Grist, Emily |
|
2015 |
33 |
6 |
p. 289-294 6 p. |
artikel |
22 |
The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior
|
Leite, Katia R.M. |
|
2015 |
33 |
6 |
p. 267.e15-267.e22 2.669999733E24 p. |
artikel |
23 |
Vasculogenesis and angiogenesis in nonseminomatous testicular germ cell tumors
|
Silván, Unai |
|
2015 |
33 |
6 |
p. 268.e17-268.e28 2.6799999999732E30 p. |
artikel |